| Nov 19 |
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
|
| Nov 7 |
Tenaya Therapeutics GAAP EPS of -$0.30
|
| Nov 6 |
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Nov 3 |
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks
|
| Nov 1 |
Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation
|
| Oct 17 |
Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM
|
| Sep 21 |
Owning 43% shares,institutional owners seem interested in Tenaya Therapeutics, Inc. (NASDAQ:TNYA),
|
| Sep 3 |
Tenaya Therapeutics to Participate in Upcoming Investment Conferences
|
| Aug 9 |
Tenaya Therapeutics GAAP EPS of -$0.34
|
| Aug 8 |
Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
|
